vs
Amarin Corp plc（AMRN）与Ardmore Shipping Corp（ASC）财务数据对比。点击上方公司名可切换其他公司
Ardmore Shipping Corp的季度营收约是Amarin Corp plc的1.8倍（$81.2M vs $45.1M），Ardmore Shipping Corp净利率更高（15.7% vs -23.3%，领先39.0%），Amarin Corp plc同比增速更快（7.0% vs -15.5%），过去两年Ardmore Shipping Corp的营收复合增速更高（-6.0% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
阿德莫尔航运是一家全球化海上运输企业，持有并运营中型成品油轮与化学品运输船队，可为全球能源、化工及贸易领域客户提供石油产品、特种化学品及其他散装液态货物的海运服务。
AMRN vs ASC — 直观对比
营收规模更大
ASC
是对方的1.8倍
$45.1M
营收增速更快
AMRN
高出22.5%
-15.5%
净利率更高
ASC
高出39.0%
-23.3%
两年增速更快
ASC
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $81.2M |
| 净利润 | $-10.5M | $12.8M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 16.1% |
| 净利率 | -23.3% | 15.7% |
| 营收同比 | 7.0% | -15.5% |
| 净利润同比 | 33.0% | -47.0% |
| 每股收益（稀释后） | — | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNASC
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | — | ||
| Q3 25 | $49.7M | $81.2M | ||
| Q2 25 | $72.7M | $72.0M | ||
| Q1 25 | $42.0M | $74.0M | ||
| Q4 24 | $62.3M | — | ||
| Q3 24 | $42.3M | $96.1M | ||
| Q2 24 | $67.5M | $121.3M |
净利润AMRNASC
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-7.7M | $12.8M | ||
| Q2 25 | $-14.1M | $9.6M | ||
| Q1 25 | $-15.7M | $6.3M | ||
| Q4 24 | $-48.6M | — | ||
| Q3 24 | $-25.1M | $24.1M | ||
| Q2 24 | $1.5M | $62.7M |
毛利率AMRNASC
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNASC
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | — | ||
| Q3 25 | -22.4% | 16.1% | ||
| Q2 25 | -22.0% | 13.5% | ||
| Q1 25 | -39.9% | 8.6% | ||
| Q4 24 | -84.3% | — | ||
| Q3 24 | -59.5% | 25.4% | ||
| Q2 24 | -0.8% | 51.3% |
净利率AMRNASC
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | — | ||
| Q3 25 | -15.6% | 15.7% | ||
| Q2 25 | -19.4% | 13.3% | ||
| Q1 25 | -37.4% | 8.5% | ||
| Q4 24 | -78.0% | — | ||
| Q3 24 | -59.4% | 25.1% | ||
| Q2 24 | 2.3% | 51.7% |
每股收益（稀释后）AMRNASC
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.02 | $0.30 | ||
| Q2 25 | $-0.03 | $0.22 | ||
| Q1 25 | $-0.04 | $0.14 | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.06 | $0.55 | ||
| Q2 24 | $0.00 | $1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | — |
| 总债务越低越好 | — | $116.1M |
| 股东权益账面价值 | — | $628.2M |
| 总资产 | $645.8M | $799.8M |
| 负债/权益比越低杠杆越低 | — | 0.18× |
8季度趋势，按日历期对齐
现金及短期投资AMRNASC
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
总债务AMRNASC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $116.1M | ||
| Q2 25 | — | $25.0M | ||
| Q1 25 | — | $20.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $22.5M | ||
| Q2 24 | — | $44.2M |
股东权益AMRNASC
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | — | ||
| Q3 25 | $458.9M | $628.2M | ||
| Q2 25 | $464.9M | $618.3M | ||
| Q1 25 | $473.7M | $610.7M | ||
| Q4 24 | $486.2M | — | ||
| Q3 24 | $531.4M | $627.0M | ||
| Q2 24 | $551.9M | $617.7M |
总资产AMRNASC
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | — | ||
| Q3 25 | $659.8M | $799.8M | ||
| Q2 25 | $670.1M | $703.8M | ||
| Q1 25 | $655.7M | $690.4M | ||
| Q4 24 | $685.3M | — | ||
| Q3 24 | $750.6M | $722.8M | ||
| Q2 24 | $799.9M | $742.0M |
负债/权益比AMRNASC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $17.9M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 1.40× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNASC
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | — | ||
| Q3 25 | $-12.7M | $17.9M | ||
| Q2 25 | $16.6M | $11.2M | ||
| Q1 25 | $-12.5M | $26.3M | ||
| Q4 24 | $-13.3M | — | ||
| Q3 24 | $-2.4M | $39.9M | ||
| Q2 24 | $-2.7M | $48.4M |
现金转化率AMRNASC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.40× | ||
| Q2 25 | — | 1.17× | ||
| Q1 25 | — | 4.20× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | -1.81× | 0.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
ASC
暂无分部数据
